Future Medicine Co., Ltd.
Clinical-stage biopharma developing novel synthetic drugs for inflammation, fibrosis, and oncology.
341170 | KO
Overview
Corporate Details
- ISIN(s):
- KR7341170009
- LEI:
- Country:
- South Korea
- Address:
- 경기도 성남시 수정구 창업로 54 619호, 성남시
- Website:
- http://futuremedicine.co.kr/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Future Medicine Co., Ltd. is a clinical-stage biopharmaceutical company focused on the development of novel synthetic drugs. The company utilizes its proprietary FOCUSTM (Futuremedicine Origin Compound Universal System) platform, a technology based on nucleoside chemistry, to discover and regulate various in vivo targets. Its therapeutic pipeline addresses unmet medical needs in areas such as inflammation and fibrosis, including treatments for diabetic nephropathy and primary biliary cholangitis (PBC), as well as oncology.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-06-23 00:00 |
Regulatory News Service
기업설명회(IR)개최결과
|
Korean | 6.6 KB | ||
| 2025-06-17 00:00 |
Regulatory News Service
본점소재지변경
|
Korean | 5.1 KB | ||
| 2025-06-09 00:00 |
Report Publication Announcement
기업설명회(IR)개최
|
Korean | 7.0 KB | ||
| 2025-03-28 00:00 |
Post-Annual General Meeting Information
정기주주총회결과
|
Korean | 20.7 KB | ||
| 2025-03-28 00:00 |
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 9.9 KB | ||
| 2025-03-20 00:00 |
Audit Report / Information
감사보고서제출
|
Korean | 16.0 KB | ||
| 2025-03-20 00:00 |
Audit Report / Information
사업보고서 (2024.12)
|
Korean | 333.9 KB | ||
| 2025-03-13 00:00 |
Pre-Annual General Meeting Information
주주총회소집공고
|
Korean | 164.6 KB | ||
| 2025-03-13 00:00 |
Pre-Annual General Meeting Information
주주총회소집결의
|
Korean | 10.8 KB | ||
| 2025-03-13 00:00 |
Pre-Annual General Meeting Information
주주총회집중일개최사유신고
|
Korean | 5.1 KB | ||
| 2024-12-16 00:00 |
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
|
Korean | 4.1 KB | ||
| 2024-12-06 00:00 |
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
|
Korean | 22.8 KB | ||
| 2024-11-29 00:00 |
Regulatory News Service
기업설명회(IR)개최결과
|
Korean | 6.6 KB | ||
| 2024-11-21 00:00 |
Report Publication Announcement
기업설명회(IR)개최
|
Korean | 7.0 KB | ||
| 2024-07-19 00:00 |
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
|
Korean | 23.0 KB |
Automate Your Workflow. Get a real-time feed of all Future Medicine Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Future Medicine Co., Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Future Medicine Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
